You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 5, May 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetics, Other
 •Alert me on articles by topic

Spinocerebellar Ataxia Type 1 in China

Molecular Analysis and Genotype-Phenotype Correlation in 5 Families

Yong-Xing Zhou, MD, PhD; Wen-Hui Qiao, MD; Wei-Hong Gu, MD; Heng Xie, MD, PhD, MPH; Bei-Sha Tang, MD; Lian-Sheng Zhou, MD; Bin-Xian Yang, MD; Yoshihisa Takiyama, MD, PhD; Shoji Tsuji, MD, PhD; Hui-Yu He, MD; Chu-Xia Deng, PhD; Lev G. Goldfarb, MD, PhD; Guo-Xiang Wang, MD, PhD

Arch Neurol. 2001;58:789-794.

Background  Twelve genetic types of autosomal dominant hereditary ataxia have been recently identified and the genes responsible for most of them cloned. Molecular identification of the type of ataxia is important to determine the disease prevalence and its natural history in various populations.

Objectives  To perform molecular analysis of 75 Chinese families affected with spinocerebellar ataxia (SCA) and to evaluate the spectrum of mutations in these genes and the correlation between genotypes and phenotypes in Chinese patients.

Setting  Neurogenetics Unit, China-Japan Friendship Hospital, Beijing, China.

Methods  One hundred nine patients from 75 kindreds diagnosed as having autosomal dominant SCA, 16 patients with sporadic SCA or spastic paraplegia, 280 control chromosomes of the Chinese population, and 120 control chromosomes of the Sakha population were selected for this study. We conducted detailed mutational analysis by direct sequencing of polymerase chain reaction products amplified from genomic DNA.

Results  Spinocerebellar ataxia type 1 (SCA1) was identified in 5 families with 12 studied patients. All affected family members were heterozygous for a CAG repeat expansion in the SCA1 gene containing 51 to 64 trinucleotide repeats. Normal alleles had 26 to 35 repeats. Spinocerebellar ataxia type 1 accounted for 7% of the studied Chinese families with ataxia. In addition, we determined the frequency of a single vs double CAT interruption in 120 control chromosomes of the Siberian Sakha population, which has the highest known prevalence of SCA1, and compared this with 280 control chromosomes from the Chinese populations. The results show that 64.7% of the Siberian normal alleles contain a single CAT interruption, whereas 92% of the Chinese had more than 1 interruption.

Conclusions  Spinocerebellar ataxia type 1 is responsible for 7% of affected families in the Chinese population. A correlation between the prevalence of SCA1 and the number of CAT interruptions in the trinucleotide chain suggests that a CAT-to-CAG substitution may have been the initial event contributing to the generation of expanded alleles and influencing relative prevalence of SCA1.


From the Neurogenetics Unit, Department of Neurology, China-Japan Friendship Hospital, Hepingli, Beijing, China (Drs Y.-X. Zhou, Gu, Yang, He, and Wang); Clinical Neurogenetics Unit, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke (Drs Y.-X. Zhou and Goldfarb) and Genetics of Development and Disease Branch (Drs Y.-X. Zhou, Qiao, and Deng), and Division of Cancer Epidemiology and Genetics, National Cancer Institute (Dr Xie), National Institutes of Health, Bethesda, Md; Institute of Neurology, Hunan Medical University, Changsha, China (Dr Tang); Department of Neurology, The First People's Hospital of Xuzhou, Xuzhou, China (Dr L.-S. Zhou); Department of Neurology, Jichi Medical School, Minamikawachi, Tochigi, Japan (Dr Takiyama); and Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan (Dr Tsuji).

Corresponding author and reprints: Yong-Xing Zhou, MD, PhD, Genetics of Development and Disease Branch, Bldg 10/9N104, NIDDK, NIH, 10 Center Dr Bethesda, MD 20892.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(5):840-841.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.